Antidiabetic prescribing patterns, quality, and economic influence in resource-l...

연구 요약

Antidiabetic prescribing patterns, quality, and economic influence in resource-limited settings: evidence from a Pakistani tertiary care hospital using WHO/INRUD indicators.

BMC health services research 학술지에 발표된 이 연구는 Saeed A, Hussain I, Gillani AH 외 연구팀이 수행하였습니다.

이 연구는 'Antidiabetic prescribing patterns, quality, and economic influence in resource-limited settings: evidence from a Pakistani tertiary care hospital using WHO/INRUD indicators.'에 대한 과학적 분석을 제공합니다.

핵심 내용

BACKGROUND: Pakistan currently has the highest prevalence of diabetes globally, making rational prescribing of antidiabetic medications essential for safe, effective, and affordable care. Similar challenges are faced across low- and middle-income countries (LMICs), where resource constraints, limited access to essential medicines, and substandard prescribing practices exacerbate the diabetes burden. This study aimed to assess the prescribing patterns, prescription quality using WHO/International Network for Rational Use of Drugs (INRUD) indicators, potential drug-drug interactions (pDDIs), and estimated drug costs. METHODS: A cross-sectional study was conducted in the outpatient department of a large tertiary care hospital in Abbottabad, Pakistan. Four hundred and sixty-seven patient prescriptions were collected through consecutive sampling. Prescriptions were comprehensively analyzed for prescribing patterns, WHO/INRUD core indicators, and pDDIs using online drug interaction checkers. The estimated prescription cost and cost by therapeutic category were calculated to assess the approximate economic burden of antidiabetic treatment. Descriptive statistics, including frequencies, percentages, means, and standard deviations, were calculated for key study variables. RESULTS: The most frequently prescribed antidiabetic drug was Sitagliptin/Metformin combination (n = 266). The study revealed concerning prescribing practices: excessive polypharmacy (average 3.16 drugs per prescription; 23.77% with ≥ 5 drugs), poor generic prescribing (2.58%), and suboptimal compliance with the National Essential Medicines List (NEML, 59.52%). The mean prescription cost was PKR 3,404.7 ± 2,316.9 (≈ USD 12.6), with the highest estimated costs observed for insulins, followed by combination oral anti-diabetics. Gaps in medical history recording (19.1%) and route of administration (19.5%) were found in prescription documentation. CONCLUSION: Findings highlighted significant deviations from rational prescribing standards and a considerable economic burden, primarily from non-NEML medications. These results mirror challenges seen across LMICs, where gaps in rational medicine use, essential medicines policy, and affordability persist. Targeted interventions such as prescriber training for cost-conscious prescription, formulary policy alignment, standardized documentation systems, and pDDI monitoring are essential to optimize diabetes care quality, safety, and affordability in resource-limited settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-025-13783-6.

일반인을 위한 해석

구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.

실천 사항

• 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
• 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
• 이상 반응이 나타나면 즉시 전문가에게 문의하세요

의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41578267)

📄 [전문 보기 (Markdown)](fulltext/41578267-antidiabetic-prescribing-patterns-quality-and-economic-influ.md)